TD Asset Management
RLAY icon

TD Asset Management’s Relay Therapeutics RLAY Stock Holding History

TD Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.51M Buy
347,946
+133,776
+62% +$1.94M 0.01% 756
2026
Q1 		$2.13M Buy
214,170
+32,182
+18% +$288K ﹤0.01% 951
2025
Q4 		$1.54M Buy
181,988
+63,732
+54% +$455K ﹤0.01% 1036
2025
Q3 		$617K Buy
118,256
+19,200
+19% +$73.2K ﹤0.01% 1153
2025
Q2 		$343K Sell
99,056
-57,400
-37% -$171K ﹤0.01% 1151
2025
Q1 		$410K Hold
156,456
– – ﹤0.01% 1163
2024
Q4 		$645K Sell
156,456
-30,200
-16% -$164K ﹤0.01% 1160
2024
Q3 		$1.39M Sell
186,656
-19,400
-9% -$145K ﹤0.01% 1133
2024
Q2 		$1.34M Sell
206,056
-152,600
-43% -$1.04M ﹤0.01% 1105
2024
Q1 		$2.98M Sell
358,656
-109,310
-23% -$1.07M ﹤0.01% 906
2023
Q4 		$5.15M Sell
467,966
-29,524
-6% -$249K 0.01% 760
2023
Q3 		$4.18M Buy
497,490
+233,983
+89% +$2.52M 0.01% 771
2023
Q2 		$3.31M Buy
263,507
+46,690
+22% +$581K ﹤0.01% 831
2023
Q1 		$3.57M Buy
216,817
+93,255
+75% +$1.67M ﹤0.01% 828
2022
Q4 		$1.85M Buy
123,562
+4,200
+4% +$80.4K ﹤0.01% 1015
2022
Q3 		$2.76M Buy
119,362
+19,365
+19% +$425K ﹤0.01% 906
2022
Q2 		$1.68M Hold
99,997
– – ﹤0.01% 1058
2022
Q1 		$2.99M Buy
99,997
+898
+0.9% +$21.8K ﹤0.01% 963
2021
Q4 		$3.04M Buy
99,099
+72,092
+267% +$2.28M ﹤0.01% 1023
2021
Q3 		$852K Buy
27,007
+4,800
+22% +$162K ﹤0.01% 1290
2021
Q2 		$720K Hold
22,207
– – ﹤0.01% 1333
2021
Q1 		$768K Buy
22,207
+3,867
+21% +$168K ﹤0.01% 1313
2020
Q4 		$762K Hold
18,340
– – ﹤0.01% 1242
2020
Q3 		$781K Buy
+18,340
New +$699K ﹤0.01% 1133

Other funds holding RLAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

TD Asset Management's RLAY Position: Q2 2026 in Review

TD Asset Management increased its Relay Therapeutics (RLAY) stake by 62% in Q2 2026, buying an estimated $1.94M and bringing the position to 347,946 shares worth $6.51M. The position accounts for 0.01% of the portfolio, ranked #756.

TD Asset Management first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 162 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • TD Asset Management held 347,946 shares of Relay Therapeutics worth $6.51M as of Q2 2026.
  • TD Asset Management bought 133,776 Relay Therapeutics shares in Q2 2026, an estimated $1.94M.
  • Relay Therapeutics made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #756 holding.
  • TD Asset Management first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 162 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.